Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

Peter Simmonds, Jens Bukh, Christophe Combet, Gilbert Deléage, Nobuyuki Enomoto, Stephen Feinstone, Phillippe Halfon, Geneviève Inchauspé, Carla Kuiken, Geert Maertens, Masashi Mizokami, Donald G. Murphy, Hiroaki Okamoto, Jean‐Michel Pawlotsky, François Penin, Erwin Sablon, Tadasu Shin‐I, Lieven J. Stuyver, Heinz‐Jürgen Thiel, Sergei Viazov, Amy J.

Transmission of T. cruzi infection via liver transplantation to a nonreactive recipient for Chagas' disease

Laura Barcán, Concepción Lunaó, Liliana Clara, Angel Sinagra, Alejandra Valledor, Ana María De Rissioí, Adrián Gadanoá, Myriam Martín García, Eduardo de Santibañes, Adelina Riarte – 25 August 2005 – Chagas' disease is an endemic zoonosis of South America caused by a protozoan parasite Trypanosoma cruzi. About 30% of infected people develop the disease. This disease is known to reactivate in immunocompromised hosts, such as patients with acquired immunodeficiency syndrome, leukemia, and transplantation.

Risk factors for Staphylococcus aureus infection in liver transplant recipients

Frédéric Bert, Claire Bellier, Ludovic Lassel, Valérie Lefranc, François Durand, Jacques Belghiti, France Mentré, Bruno Fantin – 25 August 2005 – Staphylococcus aureus is the leading cause of bacterial infection in liver transplant recipients. Preoperative nasal carriage of methicillin‐resistant S. aureus (MRSA) is associated with a high risk of infection. We conducted a retrospective cohort study in order to identify independent risk factors for early‐onset S. aureus infection after liver transplantation. Patients were screened preoperatively for methicillin‐susceptible S.

Emergency splenic arterial embolization for massive variceal bleeding in liver recipient with left‐sided portal hypertension

Hsin‐You Ou, Tung‐Liang Huang, Tai‐Yi Chen, Leo Leung‐Chit Tsang, Allan M. Concejero, Chao‐Long Chen, Yu‐Fan Cheng – 25 August 2005 – Splenic vein thrombosis with gastric variceal bleeding is difficult to manage, and splenectomy may be necessary to stop variceal bleeding. The authors report the case of a post–orthotopic liver transplant patient with bleeding gastric varices secondary to splenic vein thrombosis treated by partial splenic artery embolization.

Overcoming the portal steal phenomenon in auxiliary partial orthotopic liver transplantation by modulation of the venous outflow of the native liver

Dieter C. Broering, Jessica Walter, Atef F. Bassas – 25 August 2005 – The main drawback of auxiliary partial orthotopic liver transplantation (APOLT) is the competition of the portal flow between the graft and the native liver, leading to graft failure. In two patients with Crigler‐Najjar syndrome type I, the intrahepatic resistance of the native liver was increased by occluding the recipients middle hepatic vein during parenchymal transection, leading the portal flow towards the graft. This new surgical technique could encourage centers to recommence APOLT.

Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low‐dose tacrolimus regimen vs. a standard‐dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinic

Eric M. Yoshida, Paul J. Marotta, Paul D. Greig, Norman M. Kneteman, Denis Marleau, Marcelo Cantarovich, Kevork M. Peltekian, Leslie B. Lilly, Charles H. Scudamore, Vincent G. Bain, William J. Wall, Andre Roy, Robert F. Balshaw, Jeffrey S.T. Barkun – 25 August 2005 – Posttransplant chronic renal failure, secondary to calcineurin inhibitor agents, is emerging as a major problem in liver transplantation.

Subscribe to